Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Selexipag verbetert hemodynamiek, maar niet inspanningscapaciteit bij inoperabele CTEPH
jul 2022 | Pulmonale hypertensie